Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses

Vaccines against a variety of infectious diseases have been developed and tested. Although there have been some notable successes, most are less than optimal or have failed outright. There has been discussion about whether either B cells or dendritic cells (DCs) could be useful for the development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Shin-ichiro, Yamasaki, Satoru, Sato, Yusuke, Shimizu, Kanako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995044/
https://www.ncbi.nlm.nih.gov/pubmed/29915600
http://dx.doi.org/10.3389/fimmu.2018.01267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995044/
https://www.ncbi.nlm.nih.gov/pubmed/29915600
http://dx.doi.org/10.3389/fimmu.2018.01267

Ejemplares similares